Invention Grant
![Imidazo[4,5-C]pyridine and pyrrolo[2,3-C]pyridine derivatives as SSAO inhibitors](/docs/US/2019-10-01/US10428066B2/abs.jpg.600x600.jpg)
- Patent Title: Imidazo[4,5-C]pyridine and pyrrolo[2,3-C]pyridine derivatives as SSAO inhibitors
-
Application No.: US15911935Application Date: 2018-03-05
-
Publication No.: US10428066B2Publication Date: 2019-10-01
- Inventor: Max Espensen , Lee Patient , David Evans , Iain Simpson , Edward Savory
- Applicant: PROXIMAGEN, LLC
- Applicant Address: US MN Plymouth
- Assignee: PROXIMAGEN, LLC
- Current Assignee: PROXIMAGEN, LLC
- Current Assignee Address: US MN Plymouth
- Agency: Greenblum & Bernstein, P.L.C.
- Priority: GB1304526.5 20130313
- Main IPC: A61K31/40
- IPC: A61K31/40 ; C07D471/04 ; C07C53/18
![Imidazo[4,5-C]pyridine and pyrrolo[2,3-C]pyridine derivatives as SSAO inhibitors](/abs-image/US/2019/10/01/US10428066B2/abs.jpg.150x150.jpg)
Abstract:
The compounds of formula (I) are inhibitors of SSAO activity wherein V, W, X, Y, Z, R1 and R2 are as defined in the claims.
Public/Granted literature
- US20180194763A1 IMIDAZO[4,5-C]PYRIDINE AND PYRROLO[2,3-C]PYRIDINE DERIVATIVES AS SSAO INHIBITORS Public/Granted day:2018-07-12
Information query
